Sun Pharmaceutical Industries reported on 1 August its Q1 FY25 net profit rose 40 percent on-year to Rs 2,836 crore from Rs 2,023 crore in the corresponding quarter previous year, beating Street expectations. The drugmaker's April-June quarter revenue rose 6 percent to Rs 12,653 crore from Rs 11,941 crore a year ago.